Copeptin Testing During Pre-hospital Care in the Treatment of Chest Pain Suggestive of Acute Coronary Syndrome

NCT02116426 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2018-01-03

No results posted yet for this study

Summary

The main objective of our study is to evaluate the diagnostic value of copeptin testing in association with troponin HS testing during pre-hospital care (ambulance care) in the treatment of patients whose pattern of use is the occurrence chest pain suggestive of ACS but not ST+.

Conditions

Interventions

BIOLOGICAL

Blood work in the ambulance

Blood sample for copeptin and troponin HS testing is taken during ambulance care.

BIOLOGICAL

Blood work upon arrival in the emergency room

Blood in drawn for copeptin and troponin HS testing upon arrival in the emergency room.

BIOLOGICAL

Blood work at 3 hours post-arrival in the emergency room

Blood is drawn for troponin HS testing 3 hours after the patient's arrival in the emergency room.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Pierre-Géraud Claret, MD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-29
Primary Completion
2017-08-01
Completion
2017-08-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02116426 on ClinicalTrials.gov